Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapy (Q88953646)
Jump to navigation
Jump to search
scientific article published on 16 May 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapy |
scientific article published on 16 May 2018 |
Statements
Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapy (English)
Bao-Dong Qin
Xiao-Dong Jiao